Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
The 2017 Hepatitis C Community Summit – a key step on the road to elimination

In the lead-up to the annual International Liver Congress (ILC) in Amsterdam, Eberhard Schatz of the Correlation Network writes about the Hepatitis C Community Summit that will be held in Amsterdam on the 18-19th of April to focus on community-related initiatives and their key role in the hepatitis C elimination movement. Read more about the Summit and register here.

Published
14 hours ago
From
BMC Blogs Network (blog)
Gilead hepatitis C drug patent faces European challenge

International groups representing doctors and patients have launched a fresh challenge to the patent on Gilead Sciences' hepatitis C drug sofosbuvir at the European Patent Office in order to increase access to the treatment.

Published
14 hours ago
From
Reuters
Pharma could take NHS England to court over new delaying tactics

Pharma and patient groups are dismayed by new cost-capping and delaying measures, which they say will further restrict access to new medicines in England.

Published
20 hours ago
From
PharmaPhorum
Two-thirds of people with HIV/HCV co-infection in Southeast Asia in need of HCV therapy

Almost two-thirds of people with HIV/hepatitis C virus (HCV) co-infection in Asia are in need of HCV therapy with a fifth of people having cirrhosis, investigators report

Published
24 March 2017
By
Michael Carter
Optimism About HCV Treatment Comes With Caveats

Despite significant advances in treatment for individuals with HCV infection, several important issues prevail in this patient population.

Published
22 March 2017
From
Medscape
Harm reduction should address the specific needs of couples who inject drugs

The sharing of drug injecting equipment most often occurs between sexual partners, but the ways in which couples manage risks and care for each other have been

Published
21 March 2017
By
Roger Pebody
Drugs costing 8p a day could be hit by 'devastating' NHS rationing plan

At present, the NHS has 90 days to make drugs available to patients, once they have been given the green light by the National Institute of Health and Care Excellence (Nice). The new system will allow health officials an extra three years to introduce drugs, during which time they will try to negotiate cost reductions.

Published
16 March 2017
From
Telegraph
Hepatitis C in the UK

The most recent national estimates suggest that around 214,000 individuals are chronically infected with hepatitis C virus (HCV) in the UK; 160,000 of these are in England.

Published
16 March 2017
From
Public Health England
Malaysia: MOH to propose importing generic Hepatitis C meds

The Health Ministry will table a working paper to the Cabinet committee for approval to import of generic drugs to treat Hepatitis C.

Published
14 March 2017
From
Malay Mail Online
Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals

AbbVie's investigational glecaprevir/pibrentasvir treatment for hepatitis C is not expected to interact with or require dose adjustment when taken with commonly used antiretroviral regimens, offering a new option

Published
10 March 2017
By
Liz Highleyman
← First12345...216Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.